^
Association details:
Biomarker:IDH2 mutation
Cancer:Astrocytoma
Drug:carboplatin (Tubulin polymerization promoter)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
ADULT GLIOMA: IDH-MUTANT ASTROCYTOMA….Recurrent or Progressive Disease WHO grade 2, KPS ≥60...Useful in Certain Circumstances... If failure or intolerance to the preferred or other recommended regimens...Carboplatin (category 3)